- Aug 2022
-
-
Monto, A. S. (2021). The Future of SARS-CoV-2 Vaccination—Lessons from Influenza. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2113403
-
-
www.medrxiv.org www.medrxiv.org
-
Maier, B. F., Wiedermann, M., Burdinski, A., Klamser, P., Jenny, M. A., Betsch, C., & Brockmann, D. (2021). Germany’s current COVID-19 crisis is mainly driven by the unvaccinated (p. 2021.11.24.21266831). https://doi.org/10.1101/2021.11.24.21266831
-
-
www.medrxiv.org www.medrxiv.org
-
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948
-
- Apr 2022
-
twitter.com twitter.com
-
🇺🇦 Meaghan Kall. (2022, January 27). NEW: 🏴 Vaccine effectiveness (symptomatic infection) data for BA.2 {Omicron’s more infectious sister} NO difference in VE between Omicron (BA.1) and BA.2 Possibly even higher VE for BA.2 but estimates overlap See full thread 🧵 from @freja_kirsebom https://t.co/bJ7uCn2cGV [Tweet]. @kallmemeg. https://twitter.com/kallmemeg/status/1486821549458001927
-
-
twitter.com twitter.com
-
Freja Kirsebom. (2022, January 28). Two important updates from our team this week: - Vaccine effectiveness (VE) against symptomatic disease after Omicron BA.2 shows that VE remains unchanged—VE against death after Omicron BA.1 shows VE is 95% at 2+ weeks after booster 1/7 Full report https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1050721/Vaccine-surveillance-report-week-4.pdf [Tweet]. @freja_kirsebom. https://twitter.com/freja_kirsebom/status/1486730977464369160
-
-
www.covid-datascience.com www.covid-datascience.com
-
Morris, J. (2021, August 17). Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated? Covid Data Science. https://www.covid-datascience.com/post/israeli-data-how-can-efficacy-vs-severe-disease-be-strong-when-60-of-hospitalized-are-vaccinated
Tags
- delta
- age
- surge
- severe disease
- is:blog
- risk
- symptomatic
- hospitalization
- vaccine
- COVID-19
- dose
- effective
- lang:en
- Pfizer
- asymptomatic
- variant
- efficacy
Annotators
URL
-
-
twitter.com twitter.com
-
Eric Topol. (2021, April 23). Just published @TheLancet: Effect of vaccine in >23,000 health care workers https://t.co/ohy3VyHM3C Dose response: No vaccine 977 infections; 1 dose 71 infections; 2 doses 9 infections (14|8|4 per 10,000 person-days) "can prevent both symptomatic and asymptomatic infection " https://t.co/EybVBFmXrU [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1385729322472730626
-
- Mar 2022
-
www.newsweek.com www.newsweek.com
-
How Fauci fooled America | Opinion. (2021, November 1). Newsweek. https://www.newsweek.com/how-fauci-fooled-america-opinion-1643839
-
- Feb 2022
-
www.bmj.com www.bmj.com
-
Mahase, E. (2022). Omicron sub-lineage BA.2 may have “substantial growth advantage,” UKHSA reports. BMJ, 376, o263. https://doi.org/10.1136/bmj.o263
-
- Jan 2022
-
twitter.com twitter.com
-
ReconfigBehSci on Twitter: “RT @AliHMokdad: Vaccine effectiveness against BA.1 and BA.2. After 2 doses it was 9% (7-10%) and 13% (-26-40%) respectively for BA.1 and BA…” / Twitter. (n.d.). Retrieved January 30, 2022, from https://twitter.com/SciBeh/status/1487123660771106821
-
-
www.statnews.com www.statnews.com
-
Scientists try to pinpoint why rapid Covid tests are missing some cases. (2022, January 6). STAT. https://www.statnews.com/2022/01/06/scientists-try-to-pinpoint-why-rapid-covid-tests-are-missing-cases/
-
-
translational-medicine.biomedcentral.com translational-medicine.biomedcentral.com
-
Liu, Y., Ebinger, J. E., Mostafa, R., Budde, P., Gajewski, J., Walker, B., Joung, S., Wu, M., Bräutigam, M., Hesping, F., Rupieper, E., Schubert, A.-S., Zucht, H.-D., Braun, J., Melmed, G. Y., Sobhani, K., Arditi, M., Van Eyk, J. E., Cheng, S., & Fert-Bober, J. (2021). Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. Journal of Translational Medicine, 19(1), 524. https://doi.org/10.1186/s12967-021-03184-8
-
- Dec 2021
-
-
Coronavirus disease (COVID-19): How is it transmitted? (n.d.). Retrieved December 24, 2021, from https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted
-
-
twitter.com twitter.com
-
Meaghan Kall. (2021, November 15). There are 2 other impressive conclusions from this study: 1. Comparing vaccine effectiveness of booster vs “fully vaxxed” as the baseline. Booster ADDS 81-85% protection against symptomatic infection ON TOP of what you already had from your primary (2-dose) vaccination https://t.co/5EO7m6GHTZ [Tweet]. @kallmemeg. https://twitter.com/kallmemeg/status/1460207567070769156
-
- Oct 2021
-
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
-
Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology (Cambridge, Mass.), 32(6), 820–828. https://doi.org/10.1097/EDE.0000000000001415
-
- Jul 2021
-
www.ema.europa.eu www.ema.europa.eu
-
PINHO, A. C. (2021, March 11). EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU [Text]. European Medicines Agency. https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-janssen-authorisation-eu
-
-
www.bmj.com www.bmj.com
-
Griffin, S. (2021). Covid-19: China’s CoronaVac vaccine offers 83.5% protection against symptomatic infection, interim analysis finds. BMJ, 374, n1755. https://doi.org/10.1136/bmj.n1755
-
- Jun 2021
-
covid.joinzoe.com covid.joinzoe.com
-
“Cases Rising Rapidly among Those with Incomplete Vaccinations.” Accessed June 15, 2021. https://covid.joinzoe.com/post/cases-rising-rapidly-among-those-with-incomplete-vaccinations.
-
-
www.theguardian.com www.theguardian.com
-
Covid variants: How much protection do the different vaccines offer? (2021, June 3). The Guardian. http://www.theguardian.com/world/2021/jun/03/covid-variants-delta-alpha-how-much-protection-vaccines
Tags
- protection
- death
- is:news
- infection
- delta
- effectiveness
- restriction
- symptomatic
- data
- disease
- vaccine
- COVID-19
- lang:en
- England
- vaccination
- rate
- variant
- trial
- pandemic
- lift
- efficacy
Annotators
URL
-
- May 2021
-
www.nature.com www.nature.com
-
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine, 1–7. https://doi.org/10.1038/s41591-021-01377-8
-
- Mar 2021
-
twitter.com twitter.com
-
A Marm Kilpatrick. (2021, February 9). Vaccine efficacy in blocking infection & transmission (I think) We can now estimate the (minimum) reduction in transmission from the Moderna vaccine. Thread tl;dr Moderna vaccine blocks >90% (87-93%) of infections & 91% (89-94%) of transmission. *Critiques welcome! Https://t.co/GjQIo3v4oe [Tweet]. @DiseaseEcology. https://twitter.com/DiseaseEcology/status/1359213735424872450
-
-
www.thelancet.com www.thelancet.com
-
Olliaro, P. (2021). What does 95% COVID-19 vaccine efficacy really mean? The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00075-X
-
-
www.nature.com www.nature.com
-
Pullano, G., Di Domenico, L., Sabbatini, C. E., Valdano, E., Turbelin, C., Debin, M., Guerrisi, C., Kengne-Kuetche, C., Souty, C., Hanslik, T., Blanchon, T., Boëlle, P.-Y., Figoni, J., Vaux, S., Campèse, C., Bernard-Stoecklin, S., & Colizza, V. (2021). Underdetection of cases of COVID-19 in France threatens epidemic control. Nature, 590(7844), 134–139. https://doi.org/10.1038/s41586-020-03095-6
-
-
twitter.com twitter.com
-
ReconfigBehSci on Twitter: ‘RT @d_spiegel: Excellent new Covid RED dashboard from UCL https://t.co/wHMG8LzTUb Would be good to also know (a) how many contacts isolate…’ / Twitter. (n.d.). Retrieved 6 March 2021, from https://twitter.com/SciBeh/status/1323316018484305920
-
- Feb 2021
-
advances.sciencemag.org advances.sciencemag.org
-
Matrajt, Laura, Julia Eaton, Tiffany Leung, und Elizabeth R. Brown. „Vaccine Optimization for COVID-19: Who to Vaccinate First?“ Science Advances 7, Nr. 6 (1. Februar 2020): eabf1374. https://doi.org/10.1126/sciadv.abf1374.
-
- Nov 2020
-
www.nature.com www.nature.com
-
Nogrady, B. (2020). What the data say about asymptomatic COVID infections. Nature, 587(7835), 534–535. https://doi.org/10.1038/d41586-020-03141-3
-
- Aug 2020
-
royalsocietypublishing.org royalsocietypublishing.org
-
Stutt, R. O. J. H., Retkute, R., Bradley, M., Gilligan, C. A., & Colvin, J. (2020). A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic. Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences, 476(2238), 20200376. https://doi.org/10.1098/rspa.2020.0376
-
- Jul 2020
-
www.thelancet.com www.thelancet.com
-
Peeling, Rosanna W., Catherine J. Wedderburn, Patricia J. Garcia, Debrah Boeras, Noah Fongwen, John Nkengasong, Amadou Sall, Amilcar Tanuri, and David L. Heymann. ‘Serology Testing in the COVID-19 Pandemic Response’. The Lancet Infectious Diseases 0, no. 0 (17 July 2020). https://doi.org/10.1016/S1473-3099(20)30517-X.
Tags
- community
- symptomatic patients
- commercially available
- situational analysis
- immune response
- global cooperation
- COVID-19
- molecular diagnostics
- control programmes
- lang:en
- is:report
- rapid serology tests
- rapid immunodiagnostic tests
- serology testing
- serology
- viral infectivity
- surveillance
- public health
- host response
- international solidarity
Annotators
URL
-
-
www.thelancet.com www.thelancet.com
-
Mei, Q., Li, J., Du, R., Yuan, X., Li, M., & Li, J. (2020). Assessment of patients who tested positive for COVID-19 after recovery. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30433-3
-
- Jun 2020
-
arxiv.org arxiv.org
-
Maier, B. F., & Brockmann, D. (2020). Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Science, 368(6492), 742–746. https://doi.org/10.1126/science.abb4557
-
-
www.newscientist.com www.newscientist.com
-
Hamzelou, J. (2020, June 17). How many of us are likely to have caught the coronavirus so far? New Scientist. https://www.newscientist.com/article/mg24632873-000-how-many-of-us-are-likely-to-have-caught-the-coronavirus-so-far/
-
-
-
Azad, A. (2020, May 22). CDC estimates that 35% of coronavirus patients don’t have symptoms. CNN. https://www.cnn.com/2020/05/22/health/cdc-coronavirus-estimates-symptoms-deaths/index.html
-
-
fivethirtyeight.com fivethirtyeight.com
-
Koerth, M. (2020, March 31). Why It’s So Freaking Hard To Make A Good COVID-19 Model. FiveThirtyEight. https://fivethirtyeight.com/features/why-its-so-freaking-hard-to-make-a-good-covid-19-model/
-
-
jamanetwork.com jamanetwork.com
-
Cheng, H.-Y., Jian, S.-W., Liu, D.-P., Ng, T.-C., Huang, W.-T., Lin, H.-H., & for the Taiwan COVID-19 Outbreak Investigation Team. (2020). Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.2020
-
-
twitter.com twitter.com
-
The Sharing Scientist on Twitter
-
-
www.thelancet.com www.thelancet.com
-
Khalil, A., Hill, R., Ladhani, S., Pattisson, K., & O’Brien, P. (2020). COVID-19 screening of health-care workers in a London maternity hospital. The Lancet Infectious Diseases, S1473309920304035. https://doi.org/10.1016/S1473-3099(20)30403-5
-
- May 2020
-
www.thenakedscientists.com www.thenakedscientists.com
-
Smith, C. (2020, May 12). Hospital staff carrying COVID-19.https://www.thenakedscientists.com/articles/science-news/hospital-staff-carrying-covid-19
-
-
www.cdc.gov www.cdc.gov
-
Hamner L, Dubbel P, Capron I, et al. High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020;69:606–610. DOI: http://dx.doi.org/10.15585/mmwr.mm6919e6external icon
-
-
www.medrxiv.org www.medrxiv.org
-
Buitrago-Garcia, D. C., Egli-Gany, D., Counotte, M. J., Hossmann, S., Imeri, H., Salanti, G., & Low, N. (2020). The role of asymptomatic SARS-CoV-2 infections: Rapid living systematic review and meta-analysis [Preprint]. Epidemiology. https://doi.org/10.1101/2020.04.25.20079103
-
-
-
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., Eiriksdottir, B., Fridriksdottir, R., Gardarsdottir, E. E., Georgsson, G., Gretarsdottir, O. S., Gudmundsson, K. R., Gunnarsdottir, T. R., Gylfason, A., Holm, H., … Stefansson, K. (2020). Spread of SARS-CoV-2 in the Icelandic Population. New England Journal of Medicine, NEJMoa2006100. https://doi.org/10.1056/NEJMoa2006100
-
-
academic.oup.com academic.oup.com
-
Danis, K., Epaulard, O., Bénet, T., Gaymard, A., Campoy, S., Bothelo-Nevers, E., Bouscambert-Duchamp, M., Spaccaferri, G., Ader, F., Mailles, A., Boudalaa, Z., Tolsma, V., Berra, J., Vaux, S., Forestier, E., Landelle, C., Fougere, E., Thabuis, A., Berthelot, P., … Bag, B. C. (2020). Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clinical Infectious Diseases, ciaa424. https://doi.org/10.1093/cid/ciaa424
-
-
www.thelancet.com www.thelancet.com
-
Ghinai, I., McPherson, T. D., Hunter, J. C., Kirking, H. L., Christiansen, D., Joshi, K., Rubin, R., Morales-Estrada, S., Black, S. R., Pacilli, M., Fricchione, M. J., Chugh, R. K., Walblay, K. A., Ahmed, N. S., Stoecker, W. C., Hasan, N. F., Burdsall, D. P., Reese, H. E., Wallace, M., … Uyeki, T. M. (2020). First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. The Lancet, 395(10230), 1137–1144. https://doi.org/10.1016/S0140-6736(20)30607-3
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., Gao, W., Cheng, C., Tang, X., Wu, X., Wu, Y., Sun, B., Huang, S., Sun, Y., Zhang, J., … Feng, T. (2020). Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: A retrospective cohort study. The Lancet Infectious Diseases, S1473309920302875. https://doi.org/10.1016/S1473-3099(20)30287-5
-
-
www.cdc.gov www.cdc.gov
-
Burke RM, Midgley CM, Dratch A, et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep 2020;69:245–246. DOI: http://dx.doi.org/10.15585/mmwr.mm6909e1
-
-
twitter.com twitter.com
-
Dr Muge Cevik on Twitter
Tags
- probability
- transmission reduction
- nursing home
- contact tracing
- transmission dynamics
- age
- high risk
- close contact
- exposure
- attack rate
- family
- infection rate
- symptomatic
- environment
- COVID-19
- household
- aged care facility
- lang:en
- public transport
- friends
- asymptomatic
- is:twitter
- indoors
Annotators
URL
-
-
onlinelibrary.wiley.com onlinelibrary.wiley.com
-
Casas, R. S., Cooper, J. L., & Hempel, E. V. (2020). COVID‐19 risk triage: Engaging residents in telephonic screening. Medical Education, medu.14211. https://doi.org/10.1111/medu.14211
-
-
www.theguardian.com www.theguardian.com
-
Davis, N. (2020, May 4). Report on face masks’ effectiveness for Covid-19 divides scientists. The Guardian. https://www.theguardian.com/world/2020/may/04/scientists-disagree-over-face-masks-effect-on-covid-19
Tags
- protection
- is:news
- transmission reduction
- effectiveness
- expert
- protective mask
- Data Evaluation and Learning for Viral Epidemics
- pre-symptomatic
- medical equipment
- doubt
- physical distancing
- face mask
- COVID-19
- lang:en
- concern
- social distancing
- Delve
- Royal Society
- evidence
- asymptomatic
- critical
Annotators
URL
-
-
jamanetwork.com jamanetwork.com
-
Steinbrook, R. (2020). Contact Tracing, Testing, and Control of COVID-19—Learning From Taiwan. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.2072
-
- Apr 2020
-
cmmid.github.io cmmid.github.io
-
Russell, T.W., Hellewell, J., Abbott, S., Golding, N.,Gibbs, H., Jarvis, C.I., van Zandvoort, K., Flasche, S., Eggo, R., Edmunds, W.J., Kucharski., A.J. (2020, March 22). Using a delay-adjusted case fatality ratio to estimate under-reporting. CMMID Repository. https://cmmid.github.io/topics/covid19/global_cfr_estimates.html
-
-
cmmid.github.io cmmid.github.io
-
Russel, T.W., Hellewell, J., Abbott, S., Golding, N., Gibbs, H., Jarvis, C.I., van Zandvoort, K., Flasche, S., Eggo, R., Edmunds, W.J., Kucharski, A.J., (2020). Using a delay-adjusted case fatality ratio to estimate under-reporting. CMMID. https://cmmid.github.io/topics/covid19/severity/global_cfr_estimates.html
-
-
www.thelancet.com www.thelancet.com
-
Black, J. R. M., Bailey, C., Przewrocka, J., Dijkstra, K. K., & Swanton, C. (2020). COVID-19: The case for health-care worker screening to prevent hospital transmission. The Lancet, S014067362030917X. https://doi.org/10.1016/S0140-6736(20)30917-X
-